Rapid Dose Therapeutics Corp. announced earnings results for the third quarter ended November 30, 2020. For the third quarter, the company announced total revenue was CAD 126,471 compared to negative total revenue of CAD 890,473 a year ago. Operating loss was CAD 521,034 compared to CAD 2.791 million a year ago. Net loss was CAD 511,801 compared to CAD 3.018 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.04 a year ago. For the nine months, total revenue was CAD 130,287 compared to CAD 40,206 a year ago. Operating loss was CAD 1.451 million compared to CAD 6.697 million a year ago. Net loss was CAD 1.449 million compared to CAD 6.993 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.09 a year ago.